These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5117103)

  • 1. Observations on the efficacy of L-dopa in progressive supranuclear palsy.
    Klawans HL; Ringel SP
    Eur Neurol; 1971; 5(2):115-29. PubMed ID: 5117103
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the range of efficacy of L-dopa.
    Klawans HL
    Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610
    [No Abstract]   [Full Text] [Related]  

  • 3. L-dopa. I.
    Br Med J; 1970 Nov; 4(5733):478-9. PubMed ID: 5481223
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa for progressive supranuclear palsy.
    Klawans HL
    Lancet; 1969 Dec; 2(7634):1359. PubMed ID: 4188117
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progressive supranuclear paralysis. Critical review, with a note on verbal expression disorders and action of L-dopa].
    Giménez-Roldán S; Esteban A
    Arch Neurobiol (Madr); 1972; 35(1):41-60. PubMed ID: 5060240
    [No Abstract]   [Full Text] [Related]  

  • 6. L-dopa for progressive suparanulcear palsy.
    Sacks OW
    Lancet; 1969 Sep; 2(7620):591-2. PubMed ID: 4185547
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progressive supranuclear paralysis. A case with "apraxia of the eye opening" and favorable response to treatment with L-dopa].
    Dehaene I; Bogaerts M
    Acta Neurol Belg; 1971; 71(2):141-5. PubMed ID: 5000585
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism.
    Mendell JR; Engel WK; Chase TN
    Lancet; 1970 Mar; 1(7647):593-4. PubMed ID: 4190545
    [No Abstract]   [Full Text] [Related]  

  • 9. L-dopa for progressive supranuclear palsy.
    De Renzi E; Vignolo LA
    Lancet; 1969 Dec; 2(7634):1360. PubMed ID: 4188119
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of progressive supranuclear palsy with L-dopa.
    Donaldson IM
    Aust N Z J Med; 1973 Aug; 3(4):413-6. PubMed ID: 4519129
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive external ophthalmoplegia with Parkinsonism and Dementia. Treatment with L-dopa. Report of an autopsied case.
    Rajput AH; Chornell G; Rozdilsky B
    Can J Ophthalmol; 1972 Jul; 7(3):368-74. PubMed ID: 5056570
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa for progressive supranuclear palsy.
    Gross M
    Lancet; 1969 Dec; 2(7634):1359-60. PubMed ID: 4188118
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa for progressive supranuclear palsy.
    Wagshul A; Daroff RB
    Lancet; 1969 Jul; 2(7611):105-6. PubMed ID: 4182744
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa for progressive supranuclear palsy.
    Jenkins R
    Lancet; 1969 Oct; 2(7623):742. PubMed ID: 4186183
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinsonism-dementia of Guam: treatment with L-dopa.
    Schnur JA; Chase TN; Brody JA
    Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity studies of L-dopa metabolites in reserpinized rats and their clinical significance.
    Ericsson AD; Wertman BG
    Neurology; 1971 Nov; 21(11):1129-33. PubMed ID: 5166218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations on hyperkinesis caused by L-dopa: significance of the biochemical deficit and anatomical deficit].
    Pinelli P
    Arch Psicol Neurol Psichiatr; 1970; 31(5):405-16. PubMed ID: 5502810
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of L-DOPA on the akinesis in Parkinson's syndrome].
    Bischoff A
    Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Quattroccolo G; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):62-6. PubMed ID: 5524934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.